Why hype a mothballed pre-clinical compound? Just looks like a desperation act. This is worse than the Tolero partnership that resulted in no cash.
These old news rehashes are counter productive. I bet my balls the stock closes below $1.80 tomorrow.
no dice. you are all bag and no balls, I'll wager